Method of treating fibrotic conditions

Abstract

The present invention is related to a peptidic product comprising the tetrapeptide Acetyl-glutamyl-glutamyl-glutamyl-aspartyl (SEQ ID No:5) associated with a chemical entity that is able to introduce said tetrapeptide into a cell. The present invention is also related to the pharmaceutical composition comprising at least one pharmaceutically acceptable excipient and an effective amount of the peptidic product according to the invention.

Claims aren’t available for this document.